Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Appointed director
Quarterly results

Kips Bay Medical, Inc. (KIPS) Create: Alert

All | News | Filings
Date FiledTypeDescription
09/22/2015 8-K Quarterly results
08/06/2015 8-K Quarterly results
Docs: "Kips Bay Medical Provides Business Update and Reports Second Quarter 2015 Results MINNEAPOLIS, MN, August 6, 2015 –Kips Bay Medical, Inc. , a medical device company that was focused on manufacturing and commercializing its external saphenous vein support technology, eSVS ® Mesh, for use in coronary artery bypass grafting surgery, today provided a business update and announced financial results for its second quarter ended June 27, 2015. Feasibility Study and Business Update"
07/24/2015 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Letter Agreement between Kips Bay Medical, Inc. and Manual Villafaña (Filed herewith)",
"Letter Agreement between Kips Bay Medical, Inc. and Scott Kellen (Filed herewith)"
06/29/2015 8-K Entry into a Material Definitive Agreement, Departure of Directors or Certain Officers; Election of Directors; Appointment of...
Docs: "Plan of Dissolution and Complete Liquidation of Kips Bay Medical, Inc. (Filed herewith)",
"Kips Bay Medical Announces an Orderly Wind Down of Operations with the Termination of"
05/12/2015 8-K Quarterly results
Docs: "Kips Bay Medical Provides Clinical Trial Update and Reports First Quarter 2015 Results MINNEAPOLIS, MN, May 12, 2015 –Kips Bay Medical, Inc. , a medical device company focused on manufacturing and commercializing its external saphenous vein support technology, eSVS ® Mesh, for use in coronary artery bypass grafting surgery, today provided a clinical trial update and announced financial results for its first quarter ended March 28, 2015. Feasibility Study Update"
03/24/2015 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Departure of Directors or Certain Office...
Docs: "Form of Warrant to Purchase Shares of Common Stock of Kips Bay Medical, Inc. (Filed herewith)",
"Securities Purchase Agreement, among Kips Bay Medical, Inc. and the Investors party thereto (Filed herewith)",
"Registration Rights Agreement, among Kips Bay Medical, Inc. and the Investors party thereto (Filed herewith)",
"Employment Agreement, effective as of July 1, 2015, by and between Kips Bay Medical, Inc. and Manuel A. Villafaña (Filed herewith)",
"Kips Bay Medical Announces $3.25 Million Private Placement Bridge Financing"
03/12/2015 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits
Docs: "Kips Bay Medical Announces Achievement of Enrollment Goal and Provides Business Update and Fourth Quarter and Full Year 2014 Results"
01/05/2015 8-K Other Events, Financial Statements and Exhibits
Docs: "Kips Bay Medical Reorganizes Operations and Reduces Staff to Focus on Clinical Study Work and Conserve Capital"
11/06/2014 8-K Quarterly results
Docs: "Kips Bay Medical Provides Feasibility Study Update and Reports Third Quarter 2014 Results MINNEAPOLIS, MN, November 6, 2014 – Kips Bay Medical, Inc. , a medical device company focused on manufacturing and commercializing its external saphenous vein support technology, eSVS ® Mesh, for use in coronary artery bypass grafting, or CABG, surgery, today provided a business update and announced financial results for its third quarter ended September 27, 2014. Feasibility Study Update"
10/23/2014 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
09/04/2014 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
08/12/2014 8-K Quarterly results
Docs: "Kips Bay Medical Provides Feasibility Study Update and Reports Second Quarter 2014 Results MINNEAPOLIS, MN, August 12, 2014 – Kips Bay Medical, Inc. , a medical device company focused on manufacturing and commercializing its external saphenous vein support technology, eSVS ® Mesh, for use in coronary artery bypass grafting, or CABG, surgery, today provided a business update and announced financial results for its second quarter ended June 28, 2014. Enrollment Begins at Lenox Hill Hospital in New York"
05/21/2014 8-K Submission of Matters to a Vote of Security Holders
05/08/2014 8-K Quarterly results
Docs: "Kips Bay Medical Provides Business Update and Reports First Quarter 2014 Results Minneapolis, MN, May 8, 2014 –Kips Bay Medical, Inc. , a medical device company focused on manufacturing and commercializing its external saphenous vein support technology, eSVS ® Mesh, for use in coronary artery bypass grafting surgery, today provided a business update and announced financial results for its first quarter ended March 29, 2014. Expanded IDE Approval for U.S. Study Work"
03/12/2014 8-K Quarterly results
Docs: "Kips Bay Medical Provides Business Update and Reports Fourth Quarter and Full Year 2013 Results Minneapolis, MN, March 12, 2014 –Kips Bay Medical, Inc. , a medical device company focused on manufacturing and commercializing its external saphenous vein support technology, eSVS ® Mesh, for use in coronary artery bypass grafting surgery, today provided a business update and announced financial results for its fourth quarter and full year ended December 31, 2013. FDA Update"
03/07/2014 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
02/05/2014 8-K Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits
Docs: "Certificate of Amendment to Certificate of Incorporation of Kips Bay Medical, Inc. (filed herewith)"
01/24/2014 8-K Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits
Docs: "Underwriting Agreement, between Kips Bay Medical, Inc. and Aegis Capital Corp., as Representative of the Several Underwriters named therein (filed herewith)",
"Opinion of Oppenheimer Wolff & Donnelly LLP (filed herewith)",
"Kips Bay Medical, Inc.",
"Kips Bay Medical, Inc."
01/17/2014 8-K Other Events
11/07/2013 8-K Form 8-K - Current report
09/06/2013 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
08/08/2013 8-K Quarterly results
Docs: "Kips Bay Medical Provides Business Update and Reports Second Quarter 2013 Results Minneapolis, MN, August 8, 2013 —Kips Bay Medical, Inc. , a medical device company focused on manufacturing and commercializing its external saphenous vein support technology, eSVS® Mesh, for use in coronary artery bypass grafting surgery, today provided a business update and announced financial results for its second quarter ended June 29, 2013. FDA Update"
05/09/2013 8-K Quarterly results
Docs: "Kips Bay Medical Provides FDA Update and Reports First Quarter 2013 Results"
03/28/2013 8-K Quarterly results
Docs: "Kips Bay Medical Provides FDA Update & Reports Fourth Quarter and Full Year 2012 Results Minneapolis, MN, March 28, 2013 —Kips Bay Medical, Inc. along with Manny Villafaña, its Founder, Chairman and CEO, today provided an update on its progress with the U.S. FDA and announced financial results for fourth quarter and year ended December 31, 2012. FDA Update Recent highlights:"
03/18/2013 8-K Other Events
03/04/2013 8-K Entry into a Material Definitive Agreement
12/26/2012 8-K Other Events, Financial Statements and Exhibits
Docs: "Kips Bay Medical, Inc. Manny Villafaña, Chairman and Chief Executive Officer, +1-763-235-3540 Email: [email protected] or Scott Kellen, Chief Operating Officer and Chief Financial Officer, +1-763-235-3540 Email: [email protected]"
11/13/2012 8-K Quarterly results
Docs: "Kips Bay Medical Provides FDA Update and Reports Third Quarter 2012 Results Minneapolis, MN, November 13, 2012 —Kips Bay Medical, Inc. along with Manny Villafaña, its Founder, Chairman and CEO, provides an FDA update and announces financial results for its third quarter ended September 29, 2012. FDA Update On November 8, 2012, the Company announced that the United States Food and Drug Administration has granted conditional approval of Kips Bay Medical's Investigational Device Exemption to include four U.S. study sites in the “eMESH I” clinical feasibility trial of its eSVS® Mesh. The Company is currently working through the internal review and approval process with a number of leading cardiac centers in the United States. The eMESH I clinical feasibility trial is a multi-center, rando..."
11/08/2012 8-K Other Events, Financial Statements and Exhibits
Docs: "KIPS BAY MEDICAL ANNOUNCES RECEIPT OF FDA"
09/10/2012 8-K Other Events, Financial Statements and Exhibits
Docs: "Kips Bay Medical, Inc."
08/22/2012 8-K Other Events, Financial Statements and Exhibits
Docs: "KIPS BAY MEDICAL ANNOUNCES THE COMMENCEMENT OF ITS U.S. FEASIBILITY CLINICAL TRIAL IN EUROPE AND RECRUITING OF U.S. SITES WHILE SECURING ADDITIONAL INFORMATION FOR THE FDA"
08/09/2012 8-K Quarterly results
Docs: "Kips Bay Medical Provides FDA Update and Reports Second Quarter 2012 Results Minneapolis, MN, August 9, 2012 —Kips Bay Medical, Inc. today provides an FDA update and announces financial results for its second quarter ended June 30, 2012. FDA Update As previously announced on July 18, 2012, Kips Bay Medical filed an application for an Investigational Device Exemption with the U.S. Food & Drug Administration to include four U.S. sites in the “eMESH I” clinical feasibility study of its innovative eSVS® Mesh device currently being pursued in Europe. As of the date of this press release, a number of leading cardiac centers in the U.S. have already expressed an interest in participating in the eMESH I study, pending FDA approval of the IDE. The eSVS Mesh is a highly flexible, kink-resistant tubu..."
08/02/2012 8-K Form 8-K - Current report
07/18/2012 8-K Other Events, Financial Statements and Exhibits
Docs: "KIPS BAY MEDICAL ANNOUNCES FILING THE IDE FOR A U.S. FDA STUDY"
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy